| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.506 | 2.971 | 4.743 | 2.070 | 1.102 | 101 |
| Total Income - EUR | - | - | - | - | 39.785 | 3.224 | 9.942 | 2.070 | 1.102 | 101 |
| Total Expenses - EUR | - | - | - | - | 18.605 | 18.031 | 11.727 | 3.208 | 1.590 | 56 |
| Gross Profit/Loss - EUR | - | - | - | - | 21.181 | -14.807 | -1.786 | -1.138 | -488 | 45 |
| Net Profit/Loss - EUR | - | - | - | - | 21.096 | -14.818 | -1.805 | -1.177 | -488 | 38 |
| Employees | - | - | - | - | 2 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Lexibogmed Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 10.508 | 7.164 | 4.130 | 1.526 | 0 | 0 |
| Current Assets | - | - | - | - | 13.278 | 2.890 | 1.082 | 2.109 | 3.031 | 3.071 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 13.278 | 2.890 | 1.082 | 2.109 | 3.031 | 3.071 |
| Shareholders Funds | - | - | - | - | 21.138 | 5.919 | 3.983 | 2.818 | 2.321 | 2.346 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.648 | 4.135 | 1.229 | 818 | 710 | 725 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Lexibogmed Clinique S.r.l.